Michael Annichine

Michael Annichine

CEO Magee-Womens Research Institute and Foundation
Michael Annichine

Michael Annichine is the CEO of Magee-Womens Research Institute & Foundation (MWRIF), where he leads the development to sustain programs and research at UPMC Magee-Womens Hospital and Magee-Womens Research Institute, the largest research institute in the U.S. focused solely on women’s health and reproductive biology. The research institute, based in Pittsburgh and building collaborations around the world, is home to hundreds of world-class researchers who have devoted their careers to advancing the health of women. MWRI’s medical research spans a woman’s lifetime from nine months to 90+ years and focuses on improving women’s lives by learning more about the various conditions and diseases from which they suffer. Under Michael’s leadership since 2016, MWRIF has expanded its partnerships with industry, academia, and foundations and significantly grown its revenue base while capitalizing on the translational impact of its scientific investment. Michael is a seasoned professional with more than 20 years’ experience starting, developing, and leading local and national businesses across a variety of growth industries. Prior to his current position, Michael held the Chief Executive roles at C-leveled, FlyerCity Media, and CFS Home Loans, Inc. where his companies were twice named to the Inc. 1000 Fastest Growing Companies in America list. A Carnegie Mellon University alumnus and former Director of Investment Programs at the Pittsburgh Life Sciences Greenhouse, Michael has measurably impacted the Pittsburgh start-up community and built strong connections with business, private equity, and venture capital partners

Day One - Thursday, December 3, 2026

11:00 AM Designing Better Outcomes Through Sex-Specific Data

  • Advance global women’s health outcomes by generating sex‑specific, high‑quality research that drives evidence‑based care and closes long‑standing data gaps in diagnosis, treatment, and disease understanding.
  • Transform the future of women’s health by increasing female representation in clinical trials and expanding research investment in women’s biology ensuring therapies, guidelines, and innovations are designed for the people who use them.

Check out the incredible speaker line-up to see who will be joining Michael.

Download The Latest Agenda